The number of new coronavirus cases rose by 18 per cent in the last week, with more than 4.1 million cases reported globally, according to the World Health Organisation.
The UN health agency said in its latest weekly report on the pandemic that the worldwide number of deaths remained relatively similar to the week before, at about 8,500.
COVID-related deaths increased in three regions: the Middle East, Southeast Asia and the Americas.
The biggest weekly rise in new COVID-19 cases was seen in the Middle East, where they increased by 47 per cent, according to the report released late Wednesday.
Infections rose by about 32 per cent in Europe and Southeast Asia, and by about 14 per cent in the Americas, WHO said.
WHO Director-General Tedros Adhanom Ghebreyesus said cases were on the rise in 110 countries, mostly driven by the omicron variants BA.4 and BA.5.
This pandemic is changing, but it's not over, Tedros said this week during a press briefing. He said the ability to track COVID-19's genetic evolution was under threat as countries relaxed surveillance and genetic sequencing efforts, warning that would make it more difficult to catch emerging and potentially dangerous new variants.
He called for countries to immunise their most vulnerable populations, including health workers and people over 60, saying that hundreds of millions remain unvaccinated and at risk of severe disease and death.
Tedros said that while more than 1.2 billion COVID-19 vaccines have been administered globally, the average immunization rate in poor countries is about 13 per cent.
If rich countries are vaccinating children from as young as six months old and planning to do further rounds of vaccination, it is incomprehensible to suggest that lower-income countries should not vaccinate and boost their most at risk (people), he said.
According to figures compiled by Oxfam and the People's Vaccine Alliance, fewer than half of the 2.1 billion vaccines promised to poorer countries by the Group of Seven large economies have been delivered.
Earlier this month, the US authorised COVID-19 vaccines for infants and preschoolers, rolling out a national immunisation plan targeting 18 million of the youngest children.
American regulators also recommended that some adults get updated boosters in the fall that match the latest coronavirus variants.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app